1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Muchmore, S.W. Sattler, M. Liang, H. Meadows, R.P. Harlan, J.E. Yoon, H.S. Nettesheim, D. Chang, B.S. Thompson, C.B. Wong, S.L. Ng, S.C. Fesik, S.W. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking UK Nature NATUAS 0006 0028-0836 381 335 341 10.1038/381335a0 8692274 X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death. 1996 10.2210/pdb1lxl/pdb pdb_00001lxl 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 24879.371 BCL-XL RESIDUES 1-209, LACKING THE C-TERMINAL HYDROPHOBIC REGION 1 man polymer APOPTOSIS REGULATOR BCL-X no no MSMAMSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLD AREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVD KEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERLEHHHHHH MSMAMSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLD AREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVD KEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERLEHHHHHH A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n Human Escherichia sample 9606 Homo sapiens 562 Escherichia coli HMS174 (DE3) plasmid PET29B database_2 pdbx_database_status pdbx_struct_assembly pdbx_struct_oper_list repository Initial release Version format compliance Version format compliance Database references Derived calculations Other 1 0 1997-04-21 1 1 2008-03-24 1 2 2011-07-13 1 3 2022-02-23 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_status.process_site Y BNL 1996-04-04 REL NMR SPECTRA WERE RECORDED ON 1-3 MM SOLUTIONS OF BCL-XL IN 20 MM SODIUM PHOSPHATE BUFFER (PH 7.3), 5 MM DTT AND 1MM EDTA AT 303K. 1 7.3 303 K BRUNGER refinement X-PLOR 3.1 MET -3 n 1 MET -3 A SER -2 n 2 SER -2 A MET -1 n 3 MET -1 A ALA 0 n 4 ALA 0 A MET 1 n 5 MET 1 A SER 2 n 6 SER 2 A GLN 3 n 7 GLN 3 A SER 4 n 8 SER 4 A ASN 5 n 9 ASN 5 A ARG 6 n 10 ARG 6 A GLU 7 n 11 GLU 7 A LEU 8 n 12 LEU 8 A VAL 9 n 13 VAL 9 A VAL 10 n 14 VAL 10 A ASP 11 n 15 ASP 11 A PHE 12 n 16 PHE 12 A LEU 13 n 17 LEU 13 A SER 14 n 18 SER 14 A TYR 15 n 19 TYR 15 A LYS 16 n 20 LYS 16 A LEU 17 n 21 LEU 17 A SER 18 n 22 SER 18 A GLN 19 n 23 GLN 19 A LYS 20 n 24 LYS 20 A GLY 21 n 25 GLY 21 A TYR 22 n 26 TYR 22 A SER 23 n 27 SER 23 A TRP 24 n 28 TRP 24 A SER 25 n 29 SER 25 A GLN 26 n 30 GLN 26 A PHE 27 n 31 PHE 27 A SER 28 n 32 SER 28 A ASP 29 n 33 ASP 29 A VAL 30 n 34 VAL 30 A GLU 31 n 35 GLU 31 A GLU 32 n 36 GLU 32 A ASN 33 n 37 ASN 33 A ARG 34 n 38 ARG 34 A THR 35 n 39 THR 35 A GLU 36 n 40 GLU 36 A ALA 37 n 41 ALA 37 A PRO 38 n 42 PRO 38 A GLU 39 n 43 GLU 39 A GLY 40 n 44 GLY 40 A THR 41 n 45 THR 41 A GLU 42 n 46 GLU 42 A SER 43 n 47 SER 43 A GLU 44 n 48 GLU 44 A MET 45 n 49 MET 45 A GLU 46 n 50 GLU 46 A THR 47 n 51 THR 47 A PRO 48 n 52 PRO 48 A SER 49 n 53 SER 49 A ALA 50 n 54 ALA 50 A ILE 51 n 55 ILE 51 A ASN 52 n 56 ASN 52 A GLY 53 n 57 GLY 53 A ASN 54 n 58 ASN 54 A PRO 55 n 59 PRO 55 A SER 56 n 60 SER 56 A TRP 57 n 61 TRP 57 A HIS 58 n 62 HIS 58 A LEU 59 n 63 LEU 59 A ALA 60 n 64 ALA 60 A ASP 61 n 65 ASP 61 A SER 62 n 66 SER 62 A PRO 63 n 67 PRO 63 A ALA 64 n 68 ALA 64 A VAL 65 n 69 VAL 65 A ASN 66 n 70 ASN 66 A GLY 67 n 71 GLY 67 A ALA 68 n 72 ALA 68 A THR 69 n 73 THR 69 A GLY 70 n 74 GLY 70 A HIS 71 n 75 HIS 71 A SER 72 n 76 SER 72 A SER 73 n 77 SER 73 A SER 74 n 78 SER 74 A LEU 75 n 79 LEU 75 A ASP 76 n 80 ASP 76 A ALA 77 n 81 ALA 77 A ARG 78 n 82 ARG 78 A GLU 79 n 83 GLU 79 A VAL 80 n 84 VAL 80 A ILE 81 n 85 ILE 81 A PRO 82 n 86 PRO 82 A MET 83 n 87 MET 83 A ALA 84 n 88 ALA 84 A ALA 85 n 89 ALA 85 A VAL 86 n 90 VAL 86 A LYS 87 n 91 LYS 87 A GLN 88 n 92 GLN 88 A ALA 89 n 93 ALA 89 A LEU 90 n 94 LEU 90 A ARG 91 n 95 ARG 91 A GLU 92 n 96 GLU 92 A ALA 93 n 97 ALA 93 A GLY 94 n 98 GLY 94 A ASP 95 n 99 ASP 95 A GLU 96 n 100 GLU 96 A PHE 97 n 101 PHE 97 A GLU 98 n 102 GLU 98 A LEU 99 n 103 LEU 99 A ARG 100 n 104 ARG 100 A TYR 101 n 105 TYR 101 A ARG 102 n 106 ARG 102 A ARG 103 n 107 ARG 103 A ALA 104 n 108 ALA 104 A PHE 105 n 109 PHE 105 A SER 106 n 110 SER 106 A ASP 107 n 111 ASP 107 A LEU 108 n 112 LEU 108 A THR 109 n 113 THR 109 A SER 110 n 114 SER 110 A GLN 111 n 115 GLN 111 A LEU 112 n 116 LEU 112 A HIS 113 n 117 HIS 113 A ILE 114 n 118 ILE 114 A THR 115 n 119 THR 115 A PRO 116 n 120 PRO 116 A GLY 117 n 121 GLY 117 A THR 118 n 122 THR 118 A ALA 119 n 123 ALA 119 A TYR 120 n 124 TYR 120 A GLN 121 n 125 GLN 121 A SER 122 n 126 SER 122 A PHE 123 n 127 PHE 123 A GLU 124 n 128 GLU 124 A GLN 125 n 129 GLN 125 A VAL 126 n 130 VAL 126 A VAL 127 n 131 VAL 127 A ASN 128 n 132 ASN 128 A GLU 129 n 133 GLU 129 A LEU 130 n 134 LEU 130 A PHE 131 n 135 PHE 131 A ARG 132 n 136 ARG 132 A ASP 133 n 137 ASP 133 A GLY 134 n 138 GLY 134 A VAL 135 n 139 VAL 135 A ASN 136 n 140 ASN 136 A TRP 137 n 141 TRP 137 A GLY 138 n 142 GLY 138 A ARG 139 n 143 ARG 139 A ILE 140 n 144 ILE 140 A VAL 141 n 145 VAL 141 A ALA 142 n 146 ALA 142 A PHE 143 n 147 PHE 143 A PHE 144 n 148 PHE 144 A SER 145 n 149 SER 145 A PHE 146 n 150 PHE 146 A GLY 147 n 151 GLY 147 A GLY 148 n 152 GLY 148 A ALA 149 n 153 ALA 149 A LEU 150 n 154 LEU 150 A CYS 151 n 155 CYS 151 A VAL 152 n 156 VAL 152 A GLU 153 n 157 GLU 153 A SER 154 n 158 SER 154 A VAL 155 n 159 VAL 155 A ASP 156 n 160 ASP 156 A LYS 157 n 161 LYS 157 A GLU 158 n 162 GLU 158 A MET 159 n 163 MET 159 A GLN 160 n 164 GLN 160 A VAL 161 n 165 VAL 161 A LEU 162 n 166 LEU 162 A VAL 163 n 167 VAL 163 A SER 164 n 168 SER 164 A ARG 165 n 169 ARG 165 A ILE 166 n 170 ILE 166 A ALA 167 n 171 ALA 167 A ALA 168 n 172 ALA 168 A TRP 169 n 173 TRP 169 A MET 170 n 174 MET 170 A ALA 171 n 175 ALA 171 A THR 172 n 176 THR 172 A TYR 173 n 177 TYR 173 A LEU 174 n 178 LEU 174 A ASN 175 n 179 ASN 175 A ASP 176 n 180 ASP 176 A HIS 177 n 181 HIS 177 A LEU 178 n 182 LEU 178 A GLU 179 n 183 GLU 179 A PRO 180 n 184 PRO 180 A TRP 181 n 185 TRP 181 A ILE 182 n 186 ILE 182 A GLN 183 n 187 GLN 183 A GLU 184 n 188 GLU 184 A ASN 185 n 189 ASN 185 A GLY 186 n 190 GLY 186 A GLY 187 n 191 GLY 187 A TRP 188 n 192 TRP 188 A ASP 189 n 193 ASP 189 A THR 190 n 194 THR 190 A PHE 191 n 195 PHE 191 A VAL 192 n 196 VAL 192 A GLU 193 n 197 GLU 193 A LEU 194 n 198 LEU 194 A TYR 195 n 199 TYR 195 A GLY 196 n 200 GLY 196 A ASN 197 n 201 ASN 197 A ASN 198 n 202 ASN 198 A ALA 199 n 203 ALA 199 A ALA 200 n 204 ALA 200 A ALA 201 n 205 ALA 201 A GLU 202 n 206 GLU 202 A SER 203 n 207 SER 203 A ARG 204 n 208 ARG 204 A LYS 205 n 209 LYS 205 A GLY 206 n 210 GLY 206 A GLN 207 n 211 GLN 207 A GLU 208 n 212 GLU 208 A ARG 209 n 213 ARG 209 A LEU 210 n 214 LEU 210 A GLU 211 n 215 GLU 211 A HIS 212 n 216 HIS 212 A HIS 213 n 217 HIS 213 A HIS 214 n 218 HIS 214 A HIS 215 n 219 HIS 215 A HIS 216 n 220 HIS 216 A HIS 217 n 221 HIS 217 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 1 A ARG 6 0.186 SIDE CHAIN 1 A ARG 34 0.172 SIDE CHAIN 1 A ARG 78 0.258 SIDE CHAIN 1 A ARG 91 0.237 SIDE CHAIN 1 A ARG 100 0.317 SIDE CHAIN 1 A ARG 102 0.312 SIDE CHAIN 1 A ARG 103 0.318 SIDE CHAIN 1 A ARG 132 0.202 SIDE CHAIN 1 A ARG 139 0.207 SIDE CHAIN 1 A ARG 165 0.302 SIDE CHAIN 1 A ARG 204 0.215 SIDE CHAIN 1 A ARG 209 0.191 SIDE CHAIN 1 A SER -2 -147.66 31.87 1 A ALA 0 -179.24 -51.73 1 A PHE 27 -101.22 -68.66 1 A SER 28 83.86 -45.21 1 A VAL 30 -127.32 -148.71 1 A ASN 33 58.96 174.20 1 A ARG 34 54.88 -176.87 1 A GLU 36 -153.46 24.72 1 A THR 41 -145.92 -48.01 1 A GLU 44 -159.62 -36.20 1 A MET 45 55.91 179.12 1 A SER 49 171.48 37.84 1 A ALA 50 173.63 -77.94 1 A ILE 51 40.10 90.75 1 A ASN 52 -54.43 173.18 1 A ASN 54 -179.10 71.16 1 A PRO 55 -83.87 46.12 1 A TRP 57 -97.40 -69.97 1 A HIS 58 38.61 33.16 1 A LEU 59 77.59 -77.36 1 A ASP 61 -160.99 30.51 1 A ALA 64 58.23 -91.25 1 A ASN 66 64.65 111.74 1 A ALA 68 -114.39 -77.32 1 A HIS 71 75.43 -2.90 1 A SER 72 -158.27 31.10 1 A SER 73 175.02 -44.35 1 A SER 74 -63.69 -162.93 1 A LEU 75 58.34 103.32 1 A ALA 77 -132.93 -45.48 1 A VAL 80 40.90 -159.03 1 A MET 83 168.92 -79.59 1 A ALA 84 57.27 -90.61 1 A ARG 100 -122.03 -168.59 1 A TYR 101 79.71 -72.41 1 A ARG 102 78.99 -75.50 1 A ARG 103 -65.55 -153.87 1 A ALA 104 79.87 -73.64 1 A GLN 111 -97.63 38.89 1 A LEU 112 -155.24 -64.15 1 A HIS 113 65.26 73.10 1 A THR 115 179.73 168.76 1 A PRO 116 -52.86 99.85 1 A THR 118 -52.08 174.34 1 A ALA 119 -164.23 -159.80 1 A GLN 121 -67.28 -77.20 1 A VAL 135 51.36 70.60 1 A HIS 177 -147.01 -53.08 1 A ASN 198 -54.54 -77.77 1 A ALA 199 177.30 44.02 1 A GLU 202 -129.04 -64.67 1 A GLN 207 -163.59 42.78 1 A GLU 208 77.33 -76.22 1 A ARG 209 174.96 -34.98 1 A LEU 210 67.95 -86.90 1 A GLU 211 -173.65 100.59 1 A HIS 213 -179.09 36.20 1 A HIS 214 65.83 130.03 model building X-PLOR 3.1 refinement X-PLOR 3.1 phasing X-PLOR 3.1 NMR STRUCTURE OF BCL-XL, AN INHIBITOR OF PROGRAMMED CELL DEATH, MINIMIZED AVERAGE STRUCTURE 1 Y N A GLU 7 A GLU 11 HELX_P A LYS 20 A LYS 24 1 1 14 A ALA 85 A ALA 89 HELX_P A GLU 98 A GLU 102 1 2 14 A PHE 105 A PHE 109 HELX_P A LEU 112 A LEU 116 1 3 8 A TYR 120 A TYR 124 HELX_P A PHE 131 A PHE 135 1 4 12 A TRP 137 A TRP 141 HELX_P A VAL 155 A VAL 159 1 5 19 A VAL 163 A VAL 167 HELX_P A GLU 184 A GLU 188 1 6 22 A TRP 188 A TRP 192 HELX_P A LEU 194 A LEU 198 1 7 7 APOPTOSIS APOPTOSIS, PROGRAMMED CELL DEATH, BCL-2 FAMILY BCLX_HUMAN UNP 1 1 Q07817 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREV IPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQ VLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNRWFLTGMTVAGVVLLGSLFSRK 1 209 1LXL 1 209 Q07817 A 1 5 213 1 P 1